Drug regulation reform--oversight
Subtitle: hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Publisher: U.S. G.P.O.
Published: 1980
Place of publication: Washington
Language: eng
Subjects: United States. -- Food and Drug Administration; Pharmaceutical policy -- United States; Drugs -- United States -- Testing; Pharmaceutical industry -- United States
Other titles: New drug approval process; Orphan drugs
Notes: Vol. 1: "Food and Drug Administration regulation of research, development, and marketing of drugs, June 25, 1980."

Vol. 2: "How can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980."

"Serial no. 96-170."

"Serial no. 96-216."
Table of contents: title: v. 1. New drug approval process; title: v. 2. Orphan drugs